1. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1
   Chuan Hu et al, 2020, Journal of Biosciences CrossRef
2. High expression of STAT3 within the tumour‐associated stroma predicts poor outcome in breast cancer patients
   Elizabeth Morrow et al, 2023, Cancer Medicine CrossRef
3. JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer
   Nitin Patil et al, 2023, Cancers CrossRef
4. Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
   Yong Zeng et al, 2022, Frontiers in Oncology CrossRef
5. Discovery, Significance, and Utility of JAK2 Mutation in Squamous Cell Carcinoma of the Lung
   Jasmin Hundal et al, 2022, Cureus CrossRef
6. Chromosome 1
   Ravi Gor et al, 2023, Cancer Genes CrossRef
7. Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma
   Guofeng Li et al, 2020, World Journal of Surgical Oncology CrossRef
8. Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth
   Xiaomeng Xie et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
9. Synthesis and biological evaluation of novel pyrazolo[1,5-a]pyrimidines: Discovery of a selective inhibitor of JAK1 JH2 pseudokinase and VPS34
   Justin D. Singleton et al, 2020, Bioorganic & Medicinal Chemistry Letters CrossRef
10. The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis
    Guiqin Xu et al, 2021, Oncogene CrossRef
11. Retracted: MicroRNA‐520a‐3p suppresses epithelial–mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1‐mediated JAK/STAT signaling pathway
    Chang‐Long Bi et al, 2019, Journal of Cellular Physiology CrossRef